Cancer biomarkers are measurable indicators of biological states or conditions that can help diagnose, prognosticate, and predict responses to treatment. Biomarkers can include proteins, gene mutations, extra or missing genes, and other molecules secreted by tumors or representing body responses to cancer. Some commonly used cancer biomarkers measure levels of proteins like HER2, PSA, CA125, and carcinoembryonic antigen to diagnose specific cancer types, determine prognosis, monitor therapy effectiveness, and detect recurrence of cancers like breast, prostate, ovarian, and colon cancer. Biomarkers play an important role in developing and applying new cancer therapies.